Relationship between Comorbid Hypertension and The Degree of Symptoms of COVID-19 Patients
Background: COVID-19 in Indonesia has caused 142,173 deaths, East Java is one of the provinces and Surabaya is the city with the highest death rate in Indonesia. Hypertension and cardiovascular disease are the most common comorbidities found in COVID-19 patients.
Objectives: The purpose of this study was to analyze the relationship of comorbid hypertension with the degree of symptoms of COVID-19 patients.
Methods: The type of this research is quantitative analytic observational with the type of case control study design with a sample of 104 patients. The sampling technique used is simple random sampling. The data used in this study were the medical records of patients who were confirmed positive for COVID-19 at RSUD Dr. Soetomo Surabaya for the period March 2020 to September 2021. Data analysis uses the estimated value of the Odd Ratio (OR)
Results: The results showed that the majority of elderly patients as many as 60 patients or 57.6% were male as many as 53 patients or 51%, had comorbid hypertension as many as 63 patients or 60.5% and the most common symptoms experienced by patients were colds and stones. . The results of the analysis showed that 34 patients or 72.5% had comorbid hypertension and had severe symptoms, 14 patients or 27.5% had no comorbidities and had moderate symptoms. Obtained p-value = 0.015> 0.05 so that comorbid hypertension has a significant relationship with the patient's symptoms. The estimated OR value is 2.744 (95% CI = 1.211-6215) which means that patients with hypertension have a 2.744 times greater chance of having severe symptoms than patients without hypertension..
Conclusions: The conclusion of this study is that patients with hypertension have a 2.744 times greater chance of being symptomatic than patients without hypertension. Comorbid hypertension is a risk factor for severe symptoms of COVID-19 patients.
Arif Gunawan, Kartika Prahasanti, Muhamad Reza Utama, M.P.A., 2020. Pengaruh Komorbid Hipertensi Terhadapseveritas Pasien Coronavirus Disease 2019. Universitas Muhammadiyah Surabaya, 1(2), pp.136–151.
Drew, C. and Adisasmita, A.C., 2021. Gejala dan komorbid yang memengaruhi mortalitas pasien positif COVID-19 di Jakarta Timur, Maret-September 2020. Tarumanagara Medical Journal, [online] 3(2), pp.274–283. Available at: <https://journal.untar.ac.id/index.php/tmj/article/view/11742>.
Ejaz, H., Alsrhani, A., Zafar, A., Javed, H. and Junaid, K., 2020. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ' s public news and information. Journal of Infection and Public Health, 13(January), pp.1833–1839.
Hong, J.M., Hu, L.H., Zhong, Q.S., Zhu, L.C., Hang, Y.P., Fang, X.Y., Sun, H.B., Huang, Z.H., Xu, J. and Chen, Y.H., 2020. Epidemiological Characteristics and Clinical Features of Patients Infected With the COVID-19 Virus in Nanchang, Jiangxi, China. Frontiers in Medicine, 7(November), pp.1–9. https://doi.org/10.3389/fmed.2020.571069.
Kementerian Kesehatan Republik Indonesia, 2020. Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19). Germas, [online] pp.0–115. Available at: <https://infeksiemerging.kemkes.go.id/download/REV-04_Pedoman_P2_COVID-19__27_Maret2020_TTD1.pdf [Diakses 11 Juni 2021].>.
PDPI, PERKI, PAPDI, PERDATIN and IDAI, 2020. Pedoman tatalaksana COVID-19 Edisi 3 Desember 2020. [online] Pedoman Tatalaksana COVID-19. Available at: <https://www.papdi.or.id/download/983-pedoman-tatalaksana-covid-19-edisi-3-desember-2020>.
Rahayu, L.A.D., Admiyanti, J.C., Khalda, Y.I., Ahda, F.R., Agistany, N.F.F., Setiawati, S., Shofiyanti, N.I. and Warnaini, C., 2021. Hipertensi, Diabetes Mellitus, Dan Obesitas Sebagai Faktor Komorbiditas Utama Terhadap Mortalitas Pasien Covid-19: Sebuah Studi Literatur. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 9(1), pp.90–97. https://doi.org/10.53366/jimki.v9i1.342.
Sanyaolu, A., Okorie, C., Marinkovic, A., Patidar, R., Younis, K., Desai, P., Hosein, Z., Padda, I., Mangat, J. and Altaf, M., 2020. Comorbidity and its Impact on Patients with COVID-19. SN Comprehensive Clinical Medicine, [online] 2(8), pp.1069–1076. https://doi.org/10.1007/s42399-020-00363-4.
Sun, P., Lu, X., Xu, C., Sun, W. and Pan, B., 2020. Understanding of COVID-19 based on current evidence. Journal of Medical Virology, 92(6), pp.548–551. https://doi.org/10.1002/jmv.25722.
Susilo, A., Rumende, C.M., Pitoyo, C.W., Santoso, W.D., Yulianti, M., Herikurniawan, H., Sinto, R., Singh, G., Nainggolan, L., Nelwan, E.J., Chen, L.K., Widhani, A., Wijaya, E., Wicaksana, B., Maksum, M., Annisa, F., Jasirwan, C.O.M. and Yunihastuti, E., 2020. Coronavirus Disease 2019: Tinjauan Literatur Terkini. Jurnal Penyakit Dalam Indonesia, 7(1), p.45. https://doi.org/10.7454/jpdi.v7i1.415.
Copyright (c) 2023 Inara Salsabilla, Kurnia Dwi Artanti, Santi Martini, Arief Hargono
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Media Gizi Kesmas by Unair is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author(s) to hold the copyright and to retain the publishing right of the article without restrictions.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Share-Alike (CC BY-SA).
3. The Creative Commons Attribution-Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violations.
